Please Wait.....
Report
Global Intravenous Solutions Market Report and Forecast 2023-2031
Market Report I 2023-04-21 I 147 Pages I EMR Inc.
Global Intravenous Solutions Market Report and Forecast 2023-2031
Global Intravenous Solutions Market Outlook
The growth of the global intravenous solutions market is being driven by the rising prevalence of the chronic diseases across the globe. The market value was 12.16 billion in 2022 and it is anticipated to grow at a CAGR of 7.15% during the forecast period of 2023-2031. The global intravenous solutions market is anticipated to achieve a value of USD 22.64 billion by 2031.
Intravenous Solutions: Introduction
Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's veins to provide fluids, electrolytes, medications, and nutrients. They are used to treat a variety of medical conditions such as dehydration, electrolyte imbalances, and nutrient deficiencies. IV solutions are also used to deliver medications and other therapies directly into the bloodstream.
There are several types of IV solutions available, including crystalloids, colloids, and blood products. Crystalloids are solutions that contain small molecules and are used to replace lost fluids and electrolytes. Colloids, on the other hand, contain larger molecules and are used to maintain blood volume and improve blood flow. Blood products, such as plasma and platelets, are used to treat conditions such as anaemia and bleeding disorders.
IV solutions are typically administered in hospitals, clinics, ambulatory surgical centres, and home care settings. They are administered by healthcare professionals, including nurses and doctors, who are trained in the proper administration of IV therapy.
The global IV solutions market is expected to grow significantly in the coming years due to the increasing incidence of chronic diseases, rising geriatric population, and the growing demand for parenteral nutrition therapy. Key players in the market are focused on developing new and innovative IV solutions and expanding their product portfolios to strengthen their market position.
In conclusion, IV solutions are an essential component of modern healthcare and are used to treat a wide range of medical conditions. With the increasing demand for advanced IV solutions and the expanding product portfolios of key players in the market, the global IV solutions market is expected to witness significant growth in the coming years.
Intravenous Solutions: Applications and Uses
Intravenous (IV) solutions have a wide range of applications in healthcare, including:
- Hydration therapy: IV fluids are used to treat dehydration caused by illnesses such as gastroenteritis, heat exhaustion, and kidney disease.
- Therapeutic injections: IV therapy is used to administer medications directly into the bloodstream, allowing for faster and more effective delivery than oral medications.
- Parenteral nutrition: IV solutions are used to provide essential nutrients to patients who are unable to receive adequate nutrition through oral or enteral routes.
- Blood transfusions: IV solutions are used to deliver blood products such as red blood cells, plasma, and platelets to patients who require them.
- Chemotherapy: IV therapy is used to deliver chemotherapy drugs to cancer patients, allowing for targeted delivery and minimizing the risk of side effects.
- Anaesthesia: IV solutions are used to administer anaesthesia during surgeries and medical procedures.
- Electrolyte imbalances: IV solutions are used to restore normal electrolyte balance in patients with conditions such as hyponatremia or hyperkalaemia.
- Shock: IV solutions are used to treat shock caused by trauma, infection, or other medical conditions.
Overall, IV solutions are an essential tool in modern healthcare, providing critical fluids, medications, and nutrients to patients in need. The versatility of IV therapy allows for targeted treatment of a variety of medical conditions, making it an essential component of modern medical practice.
Global Intravenous Solutions Market Segmentations
Market Breakup by Type
- Partial Parenteral Nutrition
- Total Parenteral Nutrition
Market Breakup by Nutrients
- Market Overview
- Carbohydrates
- Salts and Electrolytes
- Minerals
- Vitamins
- Amino Acids
Market Breakup by Bag Type
- Large Volume Bags (>250 mL)
- Small Volume Bags (<250 mL)
Market Breakup by Application
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
Market Breakup by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centre
- Homecare Settings
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Global Intravenous Solutions Market Scenario
The global intravenous (IV) solutions market is expected to grow significantly in the coming years, driven by factors such as the increasing incidence of chronic diseases, rising geriatric population, and the growing demand for parenteral nutrition therapy.
Crystalloids are the most commonly used type of IV solutions and are expected to continue to dominate the market during the forecast period. However, colloids are also expected to gain traction due to their advantages over crystalloids in certain applications.
The hydration therapy application segment is expected to hold the largest share of the market, driven by the increasing incidence of dehydration and the growing demand for fluid replacement therapy. The nutrition support application segment is also expected to grow significantly due to the rising prevalence of malnutrition and the increasing use of parenteral nutrition therapy.
Geographically, the market is expected to experience significant growth in North America and Europe due to the presence of well-established healthcare infrastructure and a growing demand for advanced IV solutions. However, the Asia Pacific region is expected to witness the highest growth rate due to the increasing incidence of chronic diseases and the growing geriatric population in the region.
In conclusion, the global IV solutions market is expected to witness significant growth in the coming years due to the increasing incidence of chronic diseases, rising geriatric population, and the growing demand for parenteral nutrition therapy. The market is expected to be driven by factors such as the expanding product portfolios of key players in the market, the increasing demand for advanced IV solutions, and the growing awareness about the benefits of IV therapy among healthcare professionals and patients.
Key Players in the Global Intravenous Solutions Market
The report gives an in-depth analysis of the key players involved in the global intravenous solutions market. The companies included in the market are as follows:
- Ajinomoto Health & Nutrition North America, Inc.
- B. Braun Medical Inc.
- ICU Medical, Inc.
- Baxter International, Inc.
- Fresenius Kabi AG
- Pfizer inc.
- Otsuka Pharmaceutical Co., Ltd.
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Grifols, S.A.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intravenous Solutions Market Overview
3.1 Global Intravenous Solutions Market Historical Value (2016-2022)
3.2 Global Intravenous Solutions Market Forecast Value (2023-2031)
4 Global Intravenous Solutions Market Landscape
4.1 Global Intravenous Solutions Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Intravenous Solutions Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Nutrients
4.2.3 Analysis by Bag Type
4.2.4 Analysis by Applications
4.2.5 Analysis by End User
5 Global Intravenous Solutions Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intravenous Solutions Market Segmentation
6.1 Global Intravenous Solutions Market by Type
6.1.1 Market Overview
6.1.2 Partial Parenteral Nutrition
6.1.3 Total Parenteral Nutrition
6.2 Global Intravenous Solutions Market by Nutrients
6.2.1 Market Overview
6.2.2 Carbohydrates
6.2.3 Salts and Electrolytes
6.2.4 Minerals
6.2.5 Vitamins
6.2.6 Amino Acids
6.3 Global Intravenous Solutions Market by Bag Type
6.3.1 Market Overview
6.3.2 Large Volume Bags (>250 mL)
6.3.3 Small Volume Bags (<250 mL)
6.4 Global Intravenous Solutions Market by Application
6.4.1 Market Overview
6.4.2 Basic IV Solution
6.4.3 Nutritional IV Solution
6.4.4 Blood IV Solution
6.4.5 Drug IV Solution
6.4.6 Irrigation IV Solution
6.5 Global Intravenous Solutions Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Clinics
6.5.4 Ambulatory Surgical Centres
6.5.5 Homecare Settings
6.5.6 Others
6.6 Global Intravenous Solutions Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Intravenous Solutions Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Intravenous Solutions Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Intravenous Solutions Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Intravenous Solutions Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Intravenous Solutions Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication Year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Ajinomoto Health & Nutrition North America, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 B. Braun Medical Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ICU Medical, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Baxter International, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Fresenius Kabi AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pfizer inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Otsuka Pharmaceutical Co., Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Vifor Pharma Management Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 JW Life Science
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Amanta Healthcare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Grifols, S.A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Intravenous Solutions Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security